IHH
IHH (Indian hedgehog signalling molecule, also known as HHG2 and BDA1) is a secreted morphogen of the hedgehog family that activates the smoothened signalling pathway. It is essential for bone and cartilage development, particularly in the endochondral skeleton. Browse Assay Genie's current range of IHH research reagents below, or read on for the biology behind the target.
The dually lipidated N-product of the Indian hedgehog protein acts as a morphogen. It binds the patched receptor (PTCH1 or PTCH2), which relieves the inhibition that patched places on smoothened (SMO). This activates the smoothened signalling pathway and the transcription of target genes. When IHH is absent, patched represses the constitutive signalling activity of SMO. IHH also takes part in hedgehog paracrine signalling.
In the skeleton, IHH coordinates the growth and differentiation of the endochondral skeleton. It positively regulates PTHLH expression during endochondral bone formation, which prevents chondrocyte hypertrophy. It also supports normal chondrocyte proliferation through a PTHLH-independent route. Beyond bone, IHH is involved in the development of the retinal pigment epithelium, photoreceptors and periocular tissues. When associated with very-low-density lipoprotein (VLDL) particles, it functions as a circulating morphogen that maintains endothelial cell integrity.
The IHH gene encodes a preproprotein that is proteolytically processed into several products, including the N-terminal fragment involved in signalling. The protein is found in the endoplasmic reticulum membrane, Golgi apparatus membrane, cell membrane and secreted fractions. Hedgehog family proteins are secreted signalling molecules that regulate growth, patterning and morphogenesis. Mutations in the IHH gene cause brachydactyly type A1, marked by shortened or malformed fingers and toes, and acrocapitofemoral dysplasia. The older name was Indian hedgehog (Drosophila) homolog.
IHH coordinates growth and differentiation of the endochondral skeleton and is essential for bone and cartilage development.
IHH regulates PTHLH expression to prevent chondrocyte hypertrophy, and also supports chondrocyte proliferation independently of PTHLH.
IHH binds patched to relieve SMO inhibition, making it a model ligand for studying smoothened pathway activation and paracrine signalling.
IHH contributes to retinal pigment epithelium, photoreceptor and periocular development, and circulates on VLDL particles to maintain endothelial integrity.
IHH is a secreted morphogen that binds patched (PTCH1 or PTCH2), relieving inhibition of smoothened and activating target gene transcription. It is essential for bone and cartilage development, coordinating growth and differentiation of the endochondral skeleton, and is also involved in retinal and periocular development.
IHH stands for Indian hedgehog signalling molecule. Aliases include HHG2 and BDA1, and the previous name was Indian hedgehog (Drosophila) homolog. The gene encodes a preproprotein that is proteolytically processed into several products, including the signalling N-terminal fragment.
Mutations in the IHH gene cause brachydactyly type A1 and acrocapitofemoral dysplasia. The mouse ortholog is Ihh. For work in other species, check the datasheet of any product for its validated reactivity.
Hedgehog pathway ligands, patched and smoothened signalling partners and skeletal development markers.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q14623; product specifications from Assay Genie datasheets.